One of the notable skin disorders induced by DPP-4-is is bullous pemphigoid, named as dipeptidylpeptidase 4 inhibitor-associated bullous pemphigoid (DPP4i-BP) or gliptin-associated bullous pemphigoid (GABP) [119,120]. This evidence concerns the gene DPP4 and bullous pemphigoid.